Bausch + Lomb Reports the US FDA’s Approval of enVista Envy Full Range of Vision Intraocular Lens
Shots:
- The US FDA has granted approval to enVista Envy full range of vision intraocular lens (IOL), providing continuous range of vision to enable dysphotopsia tolerance
- Approval was supported by the US study with 332 individuals, with 86% reporting minimal dysphotopsia (glare, halo, starbursts) and a Canadian study of 110 subjects, out of which 94% had little to no difficulty viewing close objects & 93% were satisfied after surgery
- enVista Envy IOLs will be available in the upcoming weeks on a limited basis across the US with a broader launch in 2025. The company is also pursuing approvals in other regions
Ref: Bausch + Lomb | Image: Bausch + Lomb
Related News:- Bausch + Lomb’s Lumify Receives the US FDA’s Approval to Treat Ocular Redness
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
